ReviewAdvanced pharmaceutical bulletin2021

DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment.

Mamta Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.